Search
for
Sort by
Research 181–210 of 1000+
- LPA-producing enzyme PA-PLA<sub>1</sub>α regulates hair follicle development by modulating EGFR signalling
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune cell regulation of the hair cycle
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Sorafenib-induced Facial Acneiform Eruption
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Wound Healing: A Cellular Perspective
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- RNA sequence analysis of dermal papilla cells’ regeneration in 3D culture
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Sesamin alleviates androgenetic alopecia by targeting the AR MAPK Wnt axis
- An autosomal recessive nonsense variant in the EGFR gene induces perinatal lethality in “Blonde d'Aquitaine” calves
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Epidermal growth factor receptor inhibitors and hair
- Cutaneous drug reactions
- Mechanism of action of herbs and their active constituents used in hair loss treatment
- The PDGF/PDGFR pathway as a drug target
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Ritlecitinib: First Approval
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Topical Inhibition of the Electron Transport Chain Can Stimulate the Hair Cycle